Delivery Order SPE2DB20D3303-SPE2DB25FA3RW
- Not listed
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,759.15 for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation has an ultimate completion date of September 9, 2025 and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL pre-filled pens, with a contract ceiling value of $2,265.90. This is a firm fixed-price, competitively awarded delivery order issued without a set-aside designation, with an ultimate completion date of August 13, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL on June 3, 2025, with performance in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with a completion date of June 4, 2025. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation, with a ceiling value of $1,132.95. This competitively awarded, non-set-aside contract was executed on May 12, 2025, with an ultimate completion date of May 13, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the contract employs firm fixed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,745.11 by the Defense Logistics Agency on August 27, 2025, with completion scheduled for August 28, 2025. The contract, awarded without set-aside designation through competitive procurement, covers the supply of Humira (adalimumab) prefilled pen injections at 40 mg/0.4 mL dosage. The delivery order was issued under a firm fixed-price arrangement...
- The Defense Logistics Agency awarded a $3,162.25 delivery order contract to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL pharmaceutical supplies. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. No set-aside designation was applied to this award, indicating...
- The Defense Logistics Agency awarded a $4,531.80 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of July 31, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL prefilled pens, with a ceiling value of $1,205.75. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 20, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $3,021.20 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL. This is a firm fixed-price contract with no set-aside designation, executed on June 3, 2025, with an ultimate completion date of June 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3RWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation, valued at $6,797.70 with a firm fixed price structure. Awarded on September 15, 2025, this non-set-aside delivery order is scheduled for completion by September 16, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen's pharmaceutical supply arrangement with DLA supports the Defense Health Agency and military healthcare systems by providing essential medications across multiple therapeutic domains. The parent IDC vehicle enables flexible procurement of brand-name and generic pharmaceuticals, specialty medications, vaccines, and related medical supplies to support military operations and healthcare requirements globally. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet federal procurement standards through competitive procurement processes, positioning it as a critical vendor for military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/15/25 |